復旦張江(01349.HK)料今年首季盈轉虧蝕最多1,980萬人幣
復旦張江(01349.HK)表示,受疫情影響,儘管公司已於2020年2月正式復工,集團三個主要產品銷量下降明顯;另個別原材料供應商受復工、運輸限制交付延遲。
經初步測算,預計2020年第一季度可實現營業收入約1,870萬至3,650萬元人民幣(下同),按年減少56%至78%;預計歸屬於母公司股東的淨虧損介乎734萬至1,980萬元,而2019年同期未經審核淨利潤為490萬元。
但公司表示,鑒於以往年度第一季度的營業收入佔全年營業收入的比例較低,相信第一季度業績下滑對2020年全年業績影響有限。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.